Cervarix(TM) Provides Longest Duration Of Sustained Neutralising Antibodies Reported For Any Vaccine Against HPV 16 And 18 Date
Cervarix(TM) Provides Longest Duration Of Sustained Neutralising Antibodies Reported For Any Vaccine Against HPV 16 And 18 Date
New data from an extended follow-up study show that CervarixTM generates sustained high levels of neutralising antibodies against the two most common cervical cancer-causing virus types for up to 6.4 years.4 This is the longest duration of sustained neutralising antibody levels reported against both virus types HPV 16 and 18 with a cervical cancer vaccine to date.
What next?
Posting Komentar